Tattoo Ink-Related Infections -- Awareness, Diagnosis, Reporting, and Prevention

LeBlanc, Pamela M.; Hollinger, Katherine A.; Klontz, Karl C.
September 2012
New England Journal of Medicine;9/13/2012, Vol. 367 Issue 11, p985
Academic Journal
The article reports on the risk of infections with pathogens associated with the process of tattooing. A 21% increase in the number of adults in the U.S. with one or more tattoos is reported for 2012. The adequacy of prevention efforts implemented at tattoo parlors has been raised due to the outbreak of nontuberculous myobacterial infections associated with contaminated tattoo ink. The efforts of the U.S. Food and Drug Administration (FDA) to address the problem is also reported.


Related Articles

  • FDA: Pet Foods May Pose Human Health Risk.  // Supermarket News Exclusive Insight;11/ 2/2011, p6 

    The article reports on the initiative of the U.S. Food and Drug Administration to remove foods serving as vehicles for transmitting pathogenic and antibiotic-resistant bacteria to humans, from the market.

  • BAK has proven history of safety, efficacy. Gonzalez, Agustin L. // Primary Care Optometry News;Sep2013, Vol. 18 Issue 9, p11 

    The article discusses the safety and efficacy of benzalkonium chloride (BAK) used as a preservative in eye drops and over-the-counter eye medications as shown in the 60-year research and clinical work.

  • Thumbs-up for irradiation.  // FoodService Director;02/15/98, Vol. 11 Issue 2, p24 

    Presents information relating to the decision by the United States Food and Drug Administration to approve irradiation to control food-bourne pathogens in red meat. Comments from Tim Hammonds, Food Marketing Institute president; Views of Herman Cain, National Restaurant Association president.

  • FDA Creates GAIN List. Serebrov, Mari // BioWorld Today;6/13/2013, Vol. 24 Issue 113, p5 

    The article reports on the creation of a list of pathogens for antibacterial and antifungal drugs by the U.S. Food and Drug Administration (FDA) under the FDA Safety and Innovation Act's Generating Antibiotic Incentives Now (GAIN) provision.

  • FDA approves kit for various lesions.  // Dermatology Times;Apr95, Vol. 16 Issue 4, p74 

    Reports that the Food and Drug Administration has approved the Verruca-Freeze Basic Kit by CryoSurgery Inc. for the treatment of over 13 types of skin lesions.

  • Cubist's Treatment for Skin Infections OK'd.  // Chain Drug Review;7/72014, Vol. 36 Issue 11, p58 

    The article reports that the U.S. Food and Drug Administration has approved Sivextro, a new drug to treat acute bacterial skin infections.

  • Are the Superbugs Winning? Shovlin, Joseph R. // Review of Optometry;Nov2008 Review of Cornea & Contact, p1 

    The article presents a study on the approval of the surveillance program, Tracking Resistance in The United States (TRUST) by the U.S. Food And Drug Administration (FDA). It was designed to test the efficacy of levofloxacin against a wide range of bacterial pathogens. It is believed that the...

  • A New Fluoroquinolone. Bowling, Ernie // Review of Optometry;Oct2009 Review of Cornea & Contact, p8 

    The article focuses on the effectiveness of Besivance, a new fluoroquinolone, in killing the antibiotic-resistant pathogens in the eye in the U.S. The U.S. Food and Drug Administration (FDA) has approved the use of Besivance as treatment of bacterial conjunctivitis because it has an excellent in...

  • Baytril use in poultry banned.  // BEEF;Sep2005, Vol. 42 Issue 1, p7 

    Reports that the Food and Drug Administration has pulled approval in late July 2005 of an antimicrobial in animal production citing a potential to lead to antibiotic-resistant pathogens in humans. Prohibition on the use of enrofloxacin (Baytril) for use to treat bacterial infections in poultry.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics